Growth Metrics

Quest Diagnostics (DGX) Other Non-Current Liabilities (2016 - 2025)

Quest Diagnostics (DGX) has disclosed Other Non-Current Liabilities for 17 consecutive years, with $957.0 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities rose 2.03% to $957.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $957.0 million through Dec 2025, up 2.03% year-over-year, with the annual reading at $957.0 million for FY2025, 2.03% up from the prior year.
  • Other Non-Current Liabilities hit $957.0 million in Q4 2025 for Quest Diagnostics, down from $982.0 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $982.0 million in Q3 2025 to a low of $6.0 million in Q2 2024.
  • Historically, Other Non-Current Liabilities has averaged $767.0 million across 5 years, with a median of $814.5 million in 2022.
  • Biggest five-year swings in Other Non-Current Liabilities: tumbled 93.18% in 2024 and later surged 14733.33% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $792.0 million in 2021, then grew by 2.53% to $812.0 million in 2022, then increased by 7.88% to $876.0 million in 2023, then grew by 7.08% to $938.0 million in 2024, then rose by 2.03% to $957.0 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for DGX at $957.0 million in Q4 2025, $982.0 million in Q3 2025, and $890.0 million in Q2 2025.